May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Lomerizine, a Novel Diphenylmethylpiperazine Calcium Antagonist, Enhances Retinal Ganglion Cell Survival Induced by Optic Nerve Damage
Author Affiliations & Notes
  • A. Sawada
    Ophthalmology, Gifu Univ School of Medicine, Gifu-Shi, Japan
  • M. Karim
    Ophthalmology, Gifu Univ School of Medicine, Gifu-Shi, Japan
  • T. Taniguchi
    Research & Development Center, Santen Pharmaceutical Co., Ltd., Nara, Japan
  • H. Kawakami
    Research & Development Center, Santen Pharmaceutical Co., Ltd., Nara, Japan
  • T. Yamamoto
    Research & Development Center, Santen Pharmaceutical Co., Ltd., Nara, Japan
  • Footnotes
    Commercial Relationships  A. Sawada, None; M. Karim, None; T. Taniguchi, Central Research Laboratories, Santen Pharmaceutical Co., Ltd., Osaka, Japan E; H. Kawakami, None; T. Yamamoto, None.
  • Footnotes
    Support  Supported by a Grant-in-Aid for scientific research from Ministry of Education, Culture, Sports, Sci
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 108. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      A. Sawada, M. Karim, T. Taniguchi, H. Kawakami, T. Yamamoto; Lomerizine, a Novel Diphenylmethylpiperazine Calcium Antagonist, Enhances Retinal Ganglion Cell Survival Induced by Optic Nerve Damage . Invest. Ophthalmol. Vis. Sci. 2003;44(13):108.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We examined the neuroprotective effect of lomerizine, a diphenylmethylpiperazine calcium channel blocker, on retinal ganglion cell (RGC) loss induced by optic nerve injury in the rat. Methods: Using a well-calibrated forceps, a crush lesion inflicted unilaterally on the optic nerve 2 mm behind the globe of adult Wistar albino rats. A sham operation was conducted to the contralateral eyes. The rats were randomly assigned into the following three groups: vehicle-treated group, and 10 or 30 mg / kg of lomerizine-treated group. Each drug was applied orally twice daily by a gastric tube until sacrifice. Intraocular pressure (IOP) was measured before and 7,14, and 28 days after acute optic nerve injury. One week before sacrifice, Fluoro-Gold (FG) was injected into the superior colliculi bilaterally to retrogradely stain surviving retinal ganglion cells (RGCs). Approximately one month after injury, retinal damage was assessed by counting FG-labeled RGCs and histologically. Results: In each group, IOP in crush eyes slightly elevated compared with sham-operated contralateral eyes during all follow-up periods. Within one month, in the control group the mean RGC density decreased to 65.9±3.5% of the contralateral eyes. Whereas, systemic applicalion of 10 mg / kg or 30 mg / kg of lomerizine significantly enhanced the RGC survival to 87.7±1.3% and 89.8±0.6%, respectively. Histological examinations showed no structural changes in each retinal layer in each group. Conclusions: Lomerizine might alleviate secondary degeneration of RGC induced by partial optic crush injury in the rat.

Keywords: animal model • pharmacology • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×